Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects
- PMID: 15563548
- DOI: 10.1210/me.2004-0040
Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects
Abstract
Suppressor of cytokine signaling-2 (SOCS2)-deficient (SOCS2-/-) mice grow significantly larger than their littermates, suggesting that SOCS2 is important in the negative regulation of the actions of GH and/or IGF-I. The aim of this study was to identify genes and metabolic parameters that might contribute to the SOCS2-/- phenotype. We demonstrate that although SOCS2 deficiency induces significant changes in hepatic gene expression, only a fraction of these overlap with known GH-induced effects in the liver, suggesting that SOCS2 might be an important regulator of other growth factors and cytokines acting on the liver. However, an important role of GH and IGF-I in the phenotype of these animals was demonstrated by an overexpression of IGF-binding protein-3 mRNA in the liver and increased levels of circulating IGF-binding protein-3. Other GH-like effects included diminished serum triglycerides and down-regulation of lipoprotein lipase in adipose tissue. Interestingly, SOCS2-/- mice did not differ from their wild-type littermates in glucose or insulin tolerance tests, which is in contrast with the known diabetogenic effects of GH. Furthermore, there was no evidence of impaired insulin signaling in primary hepatocytes isolated from SOCS2-/- mice. Moreover, increased expression of peroxisome proliferator-activated receptor-gamma coactivator-1alpha mRNA was detected in skeletal muscle, which might contribute to normal glycemic control despite the apparent overactivity of the GH/IGF-I axis. Our data indicate that SOCS2 deficiency partially mimics a state of increased GH activity, but also results in changes that cannot be related to known GH effects.
Similar articles
-
GH regulation of IGF-I and suppressor of cytokine signaling gene expression in C2C12 skeletal muscle cells.Endocrinology. 2001 Sep;142(9):3890-900. doi: 10.1210/endo.142.9.8365. Endocrinology. 2001. PMID: 11517167
-
SOCS2 negatively regulates growth hormone action in vitro and in vivo.J Clin Invest. 2005 Feb;115(2):397-406. doi: 10.1172/JCI22710. J Clin Invest. 2005. PMID: 15690087 Free PMC article.
-
Knock your SOCS off!J Clin Invest. 2005 Feb;115(2):233-6. doi: 10.1172/JCI24228. J Clin Invest. 2005. PMID: 15690080 Free PMC article. Review.
-
Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice.Endocrinology. 2006 Apr;147(4):1632-41. doi: 10.1210/en.2005-1241. Epub 2006 Jan 12. Endocrinology. 2006. PMID: 16410303
-
Role of SOCS2 in growth hormone actions.Trends Endocrinol Metab. 2005 Mar;16(2):53-8. doi: 10.1016/j.tem.2005.01.006. Trends Endocrinol Metab. 2005. PMID: 15734145 Review.
Cited by
-
Permanent uncoupling of male-specific CYP2C11 transcription/translation by perinatal glutamate.Toxicol Appl Pharmacol. 2015 Apr 1;284(1):79-91. doi: 10.1016/j.taap.2015.02.009. Epub 2015 Feb 16. Toxicol Appl Pharmacol. 2015. PMID: 25697375 Free PMC article.
-
Diabetes in Pregnancy and MicroRNAs: Promises and Limitations in Their Clinical Application.Noncoding RNA. 2018 Nov 12;4(4):32. doi: 10.3390/ncrna4040032. Noncoding RNA. 2018. PMID: 30424584 Free PMC article. Review.
-
The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.PLoS One. 2011;6(9):e25358. doi: 10.1371/journal.pone.0025358. Epub 2011 Sep 29. PLoS One. 2011. PMID: 21980433 Free PMC article.
-
Direct stimulation of bone mass by increased GH signalling in the osteoblasts of Socs2-/- mice.J Endocrinol. 2014 Oct;223(1):93-106. doi: 10.1530/JOE-14-0292. Epub 2014 Jul 29. J Endocrinol. 2014. PMID: 25074853 Free PMC article.
-
Stimulation of prolactin receptor induces STAT-5 phosphorylation and cellular invasion in glioblastoma multiforme.Oncotarget. 2016 Nov 29;7(48):79572-79583. doi: 10.18632/oncotarget.12840. Oncotarget. 2016. PMID: 27788487 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases